Company Overview
Aenorasis S.A. is a Greek pharmaceutical and medical technology company that has been successfully operating in the healthcare sector since 1998. The company is a prominent figure in the Greek healthcare ecosystem, primarily focusing on the promotion, marketing, and distribution of a wide range of effective diagnostic and therapeutic solutions. Aenorasis has established itself as a key strategic partner for major global pharmaceutical and medical device manufacturers seeking market entry and distribution in Greece. By adhering to strict regulations and quality standards, the company has secured its position as a major supplier of hospital products across Greece and a reliable education provider for healthcare professionals.
Core Business and Activities
Aenorasis's core business revolves around three main pillars: Pharmaceuticals, Medical Devices & Diagnostics, and Hospital Products. The company operates as a Marketing Authorization Holder for high-standard pharmaceutical products and an exclusive or authorized distributor for international firms. Its mission is to offer high-quality, reliable products and services, providing physicians with access to tools for early diagnosis and effective therapy. The firm's activities are strategically centered on highly specialized medical fields.
Specialized Therapeutic and Diagnostic Areas
The company focuses on promoting and distributing products and solutions in several highly specialized and critical therapeutic areas:
* Oncology
* Hematology
* Immunology
* Nuclear Medicine
* Gynecology and Women's Health
Products and Services Offered
1. Pharmaceuticals
Aenorasis distributes high-standard pharmaceutical products, acting as the sole representative for certain international pharmaceutical firms in Greece. The pharmaceutical portfolio spans key therapeutic areas like Oncology, Immunology, and Nuclear Medicine and includes different classes of medicine:
* Originators: Drugs developed through extensive laboratory and clinical research, subject to strict quality, safety, and effectiveness regulations.
* Generics: Providing cost-effective alternatives to originator drugs, thus improving patient access to effective treatments and reducing the financial burden on the national health system.
* Biosimilars: Introducing biosimilar products to the market to enhance patient access to effective treatments and allow the medical community to offer cost-effective choices.
2. Medical Devices & Diagnostics
The company's roots trace back to medical devices, a focus area since its inception in 1998. Aenorasis maintains a leading position in the provision of high-precision drug administration pumps in Greece by representing the products of globally distinguished manufacturers. This sector also encompasses innovative diagnostic products that emphasize the value of prevention and early diagnosis.
Hospital Products and Devices:
High-technology medical devices for drug administration (e.g., electronic infusion pumps).
Hemodynamic monitoring devices.
Suction systems.
Blood pressure monitoring devices.
Medical device accessories and general healthcare materials.
Women's Health Solutions: Aenorasis is an exclusive distributor of products dedicated to women's health. This includes being the exclusive distributor of a leading preparation and processing method for cytology specimens, such as the most effective prevention method against cervical cancer, as well as a series of high-accuracy diagnostic devices for detecting and identifying the Human Papillomavirus (HPV).
Laboratory Sector:
Cytology: Offering top-tier preparation and processing methods for cytology specimens.
Molecular Biology: Marketing advanced micro-array systems used for the accurate diagnosis of various types and subtypes of viruses, infections, and serious long-term conditions like osteoporosis.
In Vitro Diagnostics: Including clinical chemistry analyzers and cytology processors, along with their reagents and consumables.
3. Services and Support Infrastructure
Beyond product distribution, Aenorasis provides comprehensive support services that are integral to its operations in Greece.
* Logistics and Distribution: The company maintains a robust distribution network that covers all hospital units in Greece, facilitating the efficient trading and distribution of medical devices and pharmaceuticals.
* Technical Support: A well-organized technical support network is offered across the entire territory of Greece. This network consists of specialized technicians and a fully equipped laboratory, ensuring the installation, maintenance, and technical support of medical devices, including electronic infusion pumps, in vitro diagnostic analyzers, and cytology processors.
* Quality Management: The company operates a comprehensive Quality Management System, certified to standards such as ISO 9001:2015 and ISO 13485:2016. This system governs the trade and distribution of drugs and medical devices, as well as the technical support services, ensuring compliance with international standards and national law.
* Professional Education: Aenorasis also serves as a reliable education provider for healthcare professionals, sharing market experience and product know-how.
Please note: This information is generated by AI. For legal use, verify with company sources.
